NCT01318642 2024-11-08Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the PancreasNantBioScience, Inc.Phase 2 Terminated10 enrolled 10 charts
NCT04129151 2024-08-01Palbociclib + Ganitumab In Ewing SarcomaDana-Farber Cancer InstitutePhase 2 Terminated10 enrolled 15 charts